KA
CYRX icon

Kerrisdale Advisers’s CryoPort CYRX Stock Holding History

Kerrisdale Advisers’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Buy
+22,605
New +$290K 0.09% 102

Other funds holding CYRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Kerrisdale Advisers's CYRX Position: Q2 2026 in Review

Kerrisdale Advisers opened a new position in CryoPort (CYRX) in Q2 2026: 22,605 shares worth $355K. The stake represents 0.09% of the portfolio and ranks #102 among its holdings.

185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • Kerrisdale Advisers held 22,605 shares of CryoPort worth $355K as of Q2 2026.
  • CryoPort was a new Kerrisdale Advisers position in Q2 2026.
  • CryoPort made up 0.09% of Kerrisdale Advisers's portfolio in Q2 2026, its #102 holding.
  • 185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Kerrisdale Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.